SPEN p.Ser2139Thr
c.6416G>C · rs199976515 · VCV3050167
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0737 | likely benign |
|---|---|---|
| REVEL | 0.036 | moderately benign-leaning |
| SaProt | — | not scored · why |
| ⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 0.22 | GERP -3.9 |
| Regional constraint | o/e 0.99 | unconstrained · MANE · 1,774 bp · p 0.69 · regional, not allelic |
| Overall | ||
| CADD | 6.751 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.673% | 149 |
| Remaining individualsnot grpmax-eligible | 0.0704% | 1,420 |
| Admixed Americangrpmax | 0.00501% | 19,970 |
| European (non-Finnish) | 0.00441% | 22,686 |
| African / African-American | 0.00134% | 74,878 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SPEN
- Protein
- p.Ser2139Thr
- Coding
- c.6416G>C
- MANE Select
- NM_015001
- dbSNP
- rs199976515
- Type
- single nucleotide variant
- Location
- chr1:15932656 (GRCh38)
- Gene constraint
- LOEUF 0.094 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Residue 2139
- a UniProt-annotated variant site (in ratars); a UniProt-annotated variant site (in ratars; uncertain significance); the 'disordered' region; the 'interaction with msx2' region
Disease context
Similar variants
- SPEN p.Arg2337Ter Likely pathogenic ★★ same condition
- SPEN p.Trp2501Ter Pathogenic/Likely pathogenic ★★ same condition
- SPEN p.Asp549Glu Uncertain significance ★★ same condition
- SPEN p.Arg637Ter Likely pathogenic ★ same condition
- SPEN p.Gln2855Ter Likely pathogenic ★ same condition
- SPEN p.Ser283Ter Pathogenic ★ same condition
- SPEN p.Ala2517Val Uncertain significance ★ ⚠ same condition
- SPEN p.Ala2779Gly Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/spen-p-ser2139thr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown